Group One Trading’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.17M Sell
758,100
-443,600
-37% -$4.02M 0.01% 1140
2025
Q4
$8.08M Sell
1,201,700
-411,000
-25% -$3.1M 0.01% 1095
2025
Q3
$14M Sell
1,612,700
-262,300
-14% -$2.04M 0.02% 705
2025
Q2
$11.8M Buy
1,875,000
+758,700
+68% +$5.02M 0.03% 705
2025
Q1
$7.16M Sell
1,116,300
-284,800
-20% -$2.35M 0.02% 820
2024
Q4
$11.3M Sell
1,401,100
-210,900
-13% -$2.03M 0.03% 634
2024
Q3
$20.4M Sell
1,612,000
-830,500
-34% -$10.7M 0.06% 276
2024
Q2
$30.9M Buy
2,442,500
+1,152,200
+89% +$11.6M 0.12% 125
2024
Q1
$6.17M Buy
1,290,300
+878,400
+213% +$4.07M 0.02% 699
2023
Q4
$1.98M Sell
411,900
-8,700
-2% -$53.3K 0.01% 1887
2023
Q3
$3.05M Buy
420,600
+64,200
+18% +$513K 0.01% 1299
2023
Q2
$2.65M Buy
356,400
+158,100
+80% +$1.24M 0.01% 1447
2023
Q1
$1.37M Sell
198,300
-90,600
-31% -$834K 0.01% 1854
2022
Q4
$2.97M Buy
288,900
+78,500
+37% +$1.39M 0.01% 1499
2022
Q3
$3.83M Sell
210,400
-163,900
-44% -$7.1M 0.01% 1379
2022
Q2
$19.3M Sell
374,300
-103,900
-22% -$5.38M 0.03% 499
2022
Q1
$35.2M Sell
478,200
-106,100
-18% -$9.46M 0.03% 372
2021
Q4
$83.6M Buy
584,300
+67,100
+13% +$11.5M 0.07% 188
2021
Q3
$107M Sell
517,200
-37,500
-7% -$8.26M 0.12% 109
2021
Q2
$118M Buy
554,700
+233,700
+73% +$42.8M 0.14% 89
2021
Q1
$58.2M Buy
321,000
+98,000
+44% +$19.5M 0.09% 174
2020
Q4
$24.9M Buy
223,000
+35,500
+19% +$3.77M 0.04% 361
2020
Q3
$20.3M Sell
187,500
-105,700
-36% -$12.9M 0.06% 266
2020
Q2
$24.4M Buy
293,200
+208,000
+244% +$7.96M 0.11% 176
2020
Q1
$1.16M Sell
85,200
-11,300
-12% -$95.6K 0.01% 1415
2019
Q4
$384K Buy
96,500
+21,300
+28% +$92.4K ﹤0.01% 2653
2019
Q3
$378K Sell
75,200
-15,500
-17% -$84.8K ﹤0.01% 2572
2019
Q2
$532K Buy
90,700
+73,830
+438% +$581K ﹤0.01% 2083
2019
Q1
$186K Sell
16,870
-12,350
-42% -$390K ﹤0.01% 2761
2018
Q4
$1.07M Buy
29,220
+2,255
+8% +$87.4K 0.01% 1455
2018
Q3
$1.01M Sell
26,965
-3,080
-10% -$86.7K 0.01% 1690
2018
Q2
$805K Buy
30,045
+1,600
+6% +$54.1K 0.01% 1903
2018
Q1
$1.2M Buy
28,445
+7,060
+33% +$284K 0.01% 1373
2017
Q4
$530K Buy
21,385
+4,765
+29% +$116K ﹤0.01% 2205
2017
Q3
$379K Buy
16,620
+4,665
+39% +$104K ﹤0.01% 2295
2017
Q2
$275K Sell
11,955
-7,135
-37% -$140K ﹤0.01% 2419
2017
Q1
$489K Sell
19,090
-24,450
-56% -$672K 0.01% 1863
2016
Q4
$1.1M Sell
43,540
-68,885
-61% -$2.01M 0.01% 1261
2016
Q3
$4.68M Buy
112,425
+82,585
+277% +$10.7M 0.05% 440
2016
Q2
$4.34M Buy
29,840
+16,045
+116% +$1.84M 0.05% 449
2016
Q1
$1.42M Sell
13,795
-12,640
-48% -$1.36M 0.02% 951
2015
Q4
$4.44M Sell
26,435
-6,035
-19% -$929K 0.05% 431
2015
Q3
$4.59M Buy
32,470
+7,800
+32% +$1.75M 0.06% 374
2015
Q2
$5.5M Sell
24,670
-1,875
-7% -$330K 0.08% 288
2015
Q1
$4.39M Buy
26,545
+7,045
+36% +$1.14M 0.07% 291
2014
Q4
$2.31M Sell
19,500
-6,195
-24% -$647K 0.03% 575
2014
Q3
$2.14M Buy
25,695
+6,015
+31% +$544K 0.03% 646
2014
Q2
$1.82M Buy
19,680
+1,370
+7% +$120K 0.03% 760
2014
Q1
$1.66M Sell
18,310
-12,150
-40% -$1.36M 0.03% 734
2013
Q4
$3.12M Buy
30,460
+19,720
+184% +$1.39M 0.05% 417
2013
Q3
$679K Buy
10,740
+6,130
+133% +$345K 0.01% 1327
2013
Q2
$189K Buy
+4,610
New +$200K ﹤0.01% 2223

Other funds holding NVAX

Group One Trading's NVAX Position: Q1 2026 in Review

Group One Trading reduced its Novavax (NVAX) stake by 28% in Q1 2026, selling an estimated $1.2M and leaving 342,064 shares worth $2.78M. The position accounts for 0.01% of the portfolio, ranked #1775.

Group One Trading first reported a position in NVAX in Q2 2013 and has held it in 40 quarters since. The position peaked at $25.3M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Group One Trading held 342,064 shares of Novavax worth $2.78M as of Q1 2026.
  • Group One Trading sold 132,513 Novavax shares in Q1 2026, an estimated $1.2M.
  • Novavax made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1775 holding.
  • Group One Trading first reported a position in Novavax in Q2 2013 and has held it in 40 quarters since.
  • Group One Trading's Novavax position peaked at $25.3M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.